Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Stephanie Bela Andela - , Humboldt-Universität zu Berlin (Autor:in)
  • Holger Amthauer - , Humboldt-Universität zu Berlin (Autor:in)
  • Christian Furth - , Humboldt-Universität zu Berlin (Autor:in)
  • Julian M. Rogasch - , Humboldt-Universität zu Berlin (Autor:in)
  • Marcus Beck - , Humboldt-Universität zu Berlin (Autor:in)
  • Felix Mehrhof - , Humboldt-Universität zu Berlin (Autor:in)
  • Pirus Ghadjar - , Humboldt-Universität zu Berlin (Autor:in)
  • Jörg van den Hoff - , Helmholtz-Zentrum Dresden-Rossendorf (Autor:in)
  • Tobias Klatte - , Humboldt-Universität zu Berlin (Autor:in)
  • Rana Tahbaz - , Humboldt-Universität zu Berlin (Autor:in)
  • Daniel Zips - , Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Frank Hofheinz - , Helmholtz-Zentrum Dresden-Rossendorf (Autor:in)
  • Sebastian Zschaeck - , Humboldt-Universität zu Berlin (Autor:in)

Abstract

Background: PSMA-PET is increasingly used for staging prostate cancer (PCA) patients. However, it is not clear if quantitative imaging parameters of positron emission tomography (PET) have an impact on disease progression and are thus important for the prognosis of localized PCA. Methods: This is a monocenter retrospective analysis of 86 consecutive patients with localized intermediate or high-risk PCA and PSMA-PET before treatment The quantitative PET parameters maximum standardized uptake value (SUVmax), tumor asphericity (ASP), PSMA tumor volume (PSMA-TV), and PSMA total lesion uptake (PSMA-TLU = PSMA-TV × SUVmean) were assessed for their prognostic significance in patients with radiotherapy or surgery. Cox regression analyses were performed for biochemical recurrence-free survival, overall survival (OS), local control, and loco-regional control (LRC). Results: 67% of patients had high-risk disease, 51 patients were treated with radiotherapy, and 35 with surgery. Analysis of metric PET parameters in the whole cohort revealed a significant association of PSMA-TV (p = 0.003), PSMA-TLU (p = 0.004), and ASP (p < 0.001) with OS. Upon binarization of PET parameters, several other parameters showed a significant association with clinical outcome. When analyzing high-risk patients according to the primary treatment approach, a previously published cut-off for SUVmax (8.6) showed a significant association with LRC in surgically treated (p = 0.048), but not in primary irradiated (p = 0.34) patients. In addition, PSMA-TLU (p = 0.016) seemed to be a very promising biomarker to stratify surgical patients. Conclusion: Our data confirm one previous publication on the prognostic impact of SUVmax in surgically treated patients with high-risk PCA. Our exploratory analysis indicates that PSMA-TLU might be even better suited. The missing association with primary irradiated patients needs prospective validation with a larger sample size to conclude a predictive potential. Trial registration Due to the retrospective nature of this research, no registration was carried out.

Details

OriginalspracheEnglisch
Aufsatznummer97
FachzeitschriftRadiation oncology
Jahrgang19
Ausgabenummer1
PublikationsstatusVeröffentlicht - Dez. 2024
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 39080696

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Positron emission tomography, Prognostic value, Prostate cancer, Prostate-specific membrane antigen, PSMA, Quantitative PET parameters